UNSPSC 85493510: Supplement left ventricle with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left ventricle with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UL47Z

UNSPSC 85493510 Supplement left ventricle with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes a specific cardiac surgical procedure using tissue engineering; however, the six recent opportunities posted under this code span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, disability medical evaluation services, surgical care networks, and emergency medical services for detained youth — none of which involve left ventricular supplementation or tissue-substitute cardiac procedures.

The mismatch between the code's clinical definition and the actual procurements suggests misclassification at the issuing-body level rather than genuine market demand under this Commodity code. Activity is geographically dispersed across Arizona, Florida, California, Washington, and Texas, with issuing bodies including county governments (Collier County, Harris County, Santa Clara County), state departments (Washington State Department of Transportation), and city retirement systems (City of Phoenix). No representative opportunities directly correspond to the code's stated scope, making pursuit under this classification unlikely to yield relevant procurement intelligence for vendors offering cardiac tissue-engineering services or left ventricular augmentation procedures.